Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Headache Medicine (Online) |
Texto Completo: | https://headachemedicine.com.br/index.php/hm/article/view/1267 |
Resumo: | Background: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes. |
id |
SBC_a5aa2d47443f2d5de48526bc3907fa7c |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/1267 |
network_acronym_str |
SBC |
network_name_str |
Revista Headache Medicine (Online) |
repository_id_str |
|
spelling |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil studyMigraineMetalsMetalloidsSeleniumCadmiumIronBackground: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes.Sociedade Brasileira de Cefaleia2024-08-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://headachemedicine.com.br/index.php/hm/article/view/1267Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 125Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 1252763-6178reponame:Revista Headache Medicine (Online)instname:Sociedade Brasileira de Cefaleiainstacron:SBCenghttps://headachemedicine.com.br/index.php/hm/article/view/1267/1793Copyright (c) 2024 Arão Belitardo Oliveira, Fernando Barbosa Jr., Itamar Santos, Mario Fernando Prieto Peres, Paulo Lotufo, Isabela Benseñor, Alessandra Goulart (Author)https://creativecommons.org/licenses/by/4.0/deed.ptinfo:eu-repo/semantics/openAccessOliveira, Arão BelitardoBarbosa Jr., FernandoSantos, ItamarPeres, Mario Fernando PrietoLotufo, PauloBenseñor, IsabelaGoulart, Alessandra2024-10-01T01:01:09Zoai:ojs.pkp.sfu.ca:article/1267Revistahttp://headachemedicine.com.brPRIhttps://headachemedicine.com.br/index.php/hm/oaimmvalenca@yahoo.com.br | support@headachemedicine.com.br2763-61782178-7468opendoar:2024-10-01T01:01:09Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleiafalse |
dc.title.none.fl_str_mv |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
title |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
spellingShingle |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study Oliveira, Arão Belitardo Migraine Metals Metalloids Selenium Cadmium Iron |
title_short |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
title_full |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
title_fullStr |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
title_full_unstemmed |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
title_sort |
Association of serum metals/metalloids levels with migraine and non-migraine headache types in a 4-year follow-up analysis with 2,662 participants in the ELSA-Brasil study |
author |
Oliveira, Arão Belitardo |
author_facet |
Oliveira, Arão Belitardo Barbosa Jr., Fernando Santos, Itamar Peres, Mario Fernando Prieto Lotufo, Paulo Benseñor, Isabela Goulart, Alessandra |
author_role |
author |
author2 |
Barbosa Jr., Fernando Santos, Itamar Peres, Mario Fernando Prieto Lotufo, Paulo Benseñor, Isabela Goulart, Alessandra |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Arão Belitardo Barbosa Jr., Fernando Santos, Itamar Peres, Mario Fernando Prieto Lotufo, Paulo Benseñor, Isabela Goulart, Alessandra |
dc.subject.por.fl_str_mv |
Migraine Metals Metalloids Selenium Cadmium Iron |
topic |
Migraine Metals Metalloids Selenium Cadmium Iron |
description |
Background: Migraine disorders are thought to be influenced by a myriad of endogenous and environmental factors, including its association with metals/metalloid levels. However, this intricate relationship has never been comprehensively studied. Objective: We aimed to examine the risk of migraine disorders associated with serum levels of 16 metals/metalloids in the ELSA-Brasil study. Methods: This is a prospective analysis based on the serum levels of metals/metalloids in the baseline wave (2008-2010) and the migraine diagnosis in the inter-wave (2012-2014). Metals quantification was performed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and migraine diagnosis was based on ICHD-3, grouped as migraine without aura (MWO), migraine with aura (MWA), and non-migraine headache (NO). Modified Poisson regression models estimated the risk ratios (RR) with [95% confidence interval] for migraine diagnosis, according to metals concentration quintiles (Q), with the median as reference and 1st and 5th quintiles representing the lowest and highest metal levels, respectively. The adjusted models controlled for sex. age, education, race, smoking, alcohol intake, migraine prophylactic medication, and cardiometabolic risk factors. Results: The study included 2,662 adults, with a median (IQR) age: of 51 (45, 58) years and 52.7.0% (n = 1,403) female. In the adjusted models, 5th Q of Cu (RR: .79 [.64, .97]) and 3rd Q of Ba (RR: .86 [.76, .96]) were associated with a lower risk of NO, while 5th Q of Pb (RR: 1.16 [1.00, 1.34]) were associated with a higher risk of NO. The 1st Q of Fe (RR: 1.31 [1.01, 1.69]), 3rd Q of Ba (RR: 1.39 [1.14, 1.70]), and the 5th Q of Cd (RR: 1.35 [1.05, 1.74]) were associated with higher risk of MWO, while 5th Q of Se (RR: .70 [.50, .99]) and 3rd Q of Zn (RR: .78 [.63, .97]) were associated with lower risk of MWO. The extreme levels of Cd and Sr (5th Q and 1st Q) were associated with increased risk of MWA (RR: 1.48 [1.04, 2.10] and RR: 1.41 [1.01, 1.97], respectively). Finally, the 1st Q of Cu was associated with a lower risk of MWA (RR: .65 [.44, .97]). Conclusion: In the ELSA-Brasil, a diverse relationship was observed between metals and headaches with a higher magnitude of associations noticed with higher levels of Cd and both migraine subtypes. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-08-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/1267 |
url |
https://headachemedicine.com.br/index.php/hm/article/view/1267 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/1267/1793 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0/deed.pt info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0/deed.pt |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
dc.source.none.fl_str_mv |
Headache Medicine; Volume 15 - Supplement (2024): Abstracts from the Congresso Cefaleia 2024; 125 Headache Medicine; Volume 15 - Suplemento (2024): Resumos do Congresso Cefaleia 2024; 125 2763-6178 reponame:Revista Headache Medicine (Online) instname:Sociedade Brasileira de Cefaleia instacron:SBC |
instname_str |
Sociedade Brasileira de Cefaleia |
instacron_str |
SBC |
institution |
SBC |
reponame_str |
Revista Headache Medicine (Online) |
collection |
Revista Headache Medicine (Online) |
repository.name.fl_str_mv |
Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleia |
repository.mail.fl_str_mv |
mmvalenca@yahoo.com.br | support@headachemedicine.com.br |
_version_ |
1838629562868563968 |